Dayuse, which enables users to book hotel rooms during the day, will use the $16.3m raised in its series A round to expand internationally.

General Electric and RELX were among the investors that supplied the risk management software provider with capital as it spun out from Healthline Networks.

Lodo Therapeutics has been launched by investment firm Accelerator Corporation with series A capital from investors including AbbVie, Eli Lilly, Wuxi PharmaTech, Pfizer, IBM and Johnson & Johnson.

Aelix Therapeutics will use the $12.7m of funding to advance its HIV vaccine candidate through phase 2 clinical trials.

The gig crowdsourcing platform raised $10m in a SoftBank Ventures Korea-led round that will support international growth.

The startup, which is developing treatments for Alzheimer's disease, received the money in a Pfizer-led round that also included Takeda's corporate venturing unit.

Cancer screening test developer Grail has been spun out of biotech company Illumina with a $100m series A round co-led by Illumina and Arch Venture Partners.

AbbVie, Eli Lilly, Johnson & Johnson, Pfizer, IBM and WuXi PharmaTech are among the backers of a $48m series A round for life sciences startup Petra Pharma.